What's New in Guidelines & Advice

All documents recently added to the Guidelines & Advice area within the last 6 months are available here, as well as any updated documents.

An Endorsement of the 2018 Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline

Document Status: Current

ID: GL END 3-22

Version: N/A

Apr 2020

Recommendations for the Treatment of Patients with Clinical Stage III Non-Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance and the 2018 Society for Immunotherapy of Cancer Guidance

Document Status: Current

ID: GL END 7-3

Version: 4

Apr 2020

Regional Therapies for Colorectal Cancer Liver Metastases

Document Status: Current

ID: GL 2-30a

Version: N/A

Mar 2020

Minimal Residual Disease Testing in Acute Leukemia

Document Status: Current

ID: GL MOTAC-6

Version: N/A

Mar 2020

Pandemic Planning Clinical Guideline for Patients with Cancer

Document Status: Current

Mar 2020

Locoregional Management of In-Transit Metastasis in Melanoma

Document Status: Current

ID: GL 8-10

Version: N/A

Feb 2020

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Document Status: Current

ID: 7-A-2018-2

Version: N/A

Jan 2020

Routine Human Papilloma Virus (HPV) Testing in Squamous Cell Head and Neck Cancer

Document Status: Current

ID: 5-9

Version: 2

Jan 2020

Cannabis and cannabinoids: Cancer risk and use to manage cancer symptoms

Document Status: Current

ID: N/A

Version: 1

Jan 2020

Vaping products including e-cigarettes

Document Status: Current

ID: N/A

Version: 1

Jan 2020